CH427830A - Verfahren zur Herstellung von substituierten 1,4-Benzodiazepinen - Google Patents

Verfahren zur Herstellung von substituierten 1,4-Benzodiazepinen

Info

Publication number
CH427830A
CH427830A CH249164A CH249164A CH427830A CH 427830 A CH427830 A CH 427830A CH 249164 A CH249164 A CH 249164A CH 249164 A CH249164 A CH 249164A CH 427830 A CH427830 A CH 427830A
Authority
CH
Switzerland
Prior art keywords
benzodiazepines
substituted
preparation
Prior art date
Application number
CH249164A
Other languages
German (de)
English (en)
Inventor
Moritz Wuest Heinz
Original Assignee
Warner Lambert Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US262846A external-priority patent/US3192200A/en
Application filed by Warner Lambert Pharmaceutical filed Critical Warner Lambert Pharmaceutical
Publication of CH427830A publication Critical patent/CH427830A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/26Preparation from compounds already containing the benzodiazepine skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH249164A 1963-03-05 1964-02-28 Verfahren zur Herstellung von substituierten 1,4-Benzodiazepinen CH427830A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US262846A US3192200A (en) 1963-03-05 1963-03-05 1-cycloalkyl methyl derivatives of 1, 4-benzodiazepine
US410790A US3326757A (en) 1963-03-05 1964-11-12 Compositions and method for producing skeletal muscle relaxation

Publications (1)

Publication Number Publication Date
CH427830A true CH427830A (de) 1967-01-15

Family

ID=26949494

Family Applications (1)

Application Number Title Priority Date Filing Date
CH249164A CH427830A (de) 1963-03-05 1964-02-28 Verfahren zur Herstellung von substituierten 1,4-Benzodiazepinen

Country Status (8)

Country Link
US (1) US3326757A (xx)
BE (1) BE644705A (xx)
BR (1) BR6457243D0 (xx)
CH (1) CH427830A (xx)
DE (1) DE1470422A1 (xx)
FR (1) FR3452M (xx)
GB (1) GB1029741A (xx)
SE (1) SE309779B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911676B2 (en) 2010-10-21 2014-12-16 Guy L. McClung, III Treatment systems for fluids
US8778264B2 (en) 2010-10-28 2014-07-15 Guy L. McClung, III Fluid treatment systems

Also Published As

Publication number Publication date
GB1029741A (en) 1966-05-18
DE1470422A1 (de) 1969-11-13
BE644705A (xx) 1964-09-04
BR6457243D0 (pt) 1973-07-17
FR3452M (fr) 1965-07-26
SE309779B (xx) 1969-04-08
US3326757A (en) 1967-06-20

Similar Documents

Publication Publication Date Title
CH449643A (de) Verfahren zur Herstellung von neuen substituierten 6,7-Benzomorphanen
CH427833A (de) Verfahren zur Herstellung von neuen 1,3,5-Triazinen
CH468966A (de) Verfahren zur Herstellung von 3-Aminotricyclo-(4,3,1,1,3,8)-undecan
CH459196A (de) Verfahren zur Herstellung von 4,6-Pregnadienderivaten
CH458587A (de) Verfahren zur Herstellung von 8,9,10,11-Tetrahydro-12-phthaloperinon
CH446357A (de) Verfahren zur Herstellung von substituierten 1,4 Benzodiazepinverbindungen
CH479574A (de) Verfahren zur Herstellung von 13-Jod-14-oxo 13,14-seco-steroiden
CH460766A (de) Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden
CH430722A (de) Verfahren zur Herstellung von neuen 5,6-Dihydro-dibenz(b,e)-azepinen
CH436317A (de) Verfahren zur Herstellung von 5-Joduracil-2'-desoxyribosid-3',5'-di-Estern
AT244335B (de) Verfahren zur Herstellung von neuen 2, 1-Benzisothiazolen
CH449610A (de) Verfahren zur Herstellung von Oestra-4,9-dien-3-olen
CH427830A (de) Verfahren zur Herstellung von substituierten 1,4-Benzodiazepinen
CH459242A (de) Verfahren zur Herstellung von 1,2-Dihydro-1-hydroxy-1,3,5-triazinen
AT247848B (de) Verfahren zur Herstellung von 1, 3-Dioxo-2-alkylcyclopentanen
CH441583A (de) Verfahren zur Herstellung von 1,4-Diarylamino-5-nitro-8-hydroxy-anthrachinonen
CH439328A (de) Verfahren zur Herstellung von 3,5-Dijodthyroninen
AT240356B (de) Verfahren zur Herstellung von neuen 1, 2-Diaryl-4-alkyl-3, 5-dioxo-pyrazolidinen
AT253703B (de) Verfahren zur Herstellung von 3, 6-Dioxo-A-nor-B-homo-steroiden
CH471056A (de) Verfahren zur Herstellung von 2,5-Dialkoxybenzaldehyden
CH464174A (de) Verfahren zur Herstellung von 2,6-Dichlor-4-nitrobenzamid
CH451151A (de) Verfahren zur Herstellung von 1,4-Benzoxazin-2-onen
CH471799A (de) Verfahren zur Herstellung von 1,4-Benzodiazepinen
CH438316A (de) Verfahren zur Herstellung von substituierten 1,4-Benzoxazin-2-onen
AT258292B (de) Verfahren zur Herstellung von 3,4-Dimethyl-8-nitrochinolin